Integrating live cells with semiconductor devices: A biocompatibility assay.

Area of Science:

• Biomedical Engineering
• Cell Biology
• Materials Science

Background:

• Hybrid cell-semiconductor systems are emerging for non-invasive cellular analysis.
• Cellular viability and function on sensor materials are critical for biomedical applications.
• Bone cells require specific surface properties for optimal interaction with semiconductor substrates.

Purpose of the Study:

• To evaluate the short-term behavior of MG63 human osteosarcoma cells on silicon dioxide (SiO2) coated silicon.
• To determine the suitability of SiO2 coated silicon as a substrate for hybrid cell-semiconductor systems.
• To assess cellular adhesion, morphology, and proliferation on the tested material.

Main Methods:

• MG63 cells were cultured on SiO2 coated silicon samples for 1-7 days.
• Scanning Electron Microscopy (SEM) was used to assess cell adhesion and morphology at day 1.
• Alamar Blue assay was employed to evaluate cell proliferation at days 2, 3, and 7.

Main Results:

• No adverse cellular reactions were observed in MG63 cells cultured on SiO2 coated silicon.
• SEM analysis showed good cell adhesion and normal morphology.
• Alamar Blue assay indicated sustained cell proliferation over the 7-day period.

Conclusions:

• Silicon dioxide coated silicon surfaces support bone cell adhesion, viability, and proliferation.
• The tested substrate is suitable for developing hybrid cell-semiconductor systems for biomedical applications.
• These findings support the use of such systems for bone tumor chemosensitivity testing.